However, deletion of IKKβ in hematopoietic-derived cells slowed down the development of androgen-independent prostate cancer and inhibited the appearance of metastases [13], most likely due to reduced levels of NFκB target cytokines that may serve as growth and survival factors for cancer cells. This evidence concerns the gene IKBKB and prostate cancer.